Hi KK, yes I absolutely do, Testing, especially antibody is going to be needed for years to come. They have a low float, so a drop in the bucket for $3-5 a share for any Fund, Pharma etc to pay for them...
We know for a fact that the 43% margins make their testing VERY profitable so either way is good, but a buyout is quicker....